Print Page
Download PDFGeneral Orthopedics
Bio-Implants for General Orthopedics, Joint Repair, Oncology.
Our tissue grafts are clinically proven in more applications than any other allograft bio-implant provider. As a result, we are the world's most trusted provider of transplant solutions, from new innovations in tissue grafts and technologies to regenerative medicine and cellular therapies. Nearly 5 million tissue grafts have been distributed with no disease transmission since the introduction of Allowash XG®.
To download or print our full line of allograft bio-implants click here
General Orthopedics
Description
Cortical/cancellous shafts, designed to provide immediate structural support to restore segmental bone loss
- Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
- Structural: Cortical plate provides immediate structural support
- 100% Human Bone: Will remodel alongside patient’s own tissue during the healing process
- Pre-Hydrated: Allograft bio-implants featuring Preservon® are stored in a fully-hydrated state at ambient temperatures. Preservon eliminates thawing and re-hydration time and does not require freezer storage or compromise the graft’s inherent osteoconductive properties1
- Sterile: Sterilized using patented and proprietary Allowash XG® technology which provides a sterility assurance level (SAL) of 10-6, without compromising the graft’s inherent osteoconductive properties2
- Convenient: Implant is pre-sized to fit a variety of applications and minimize prep time in the operating room
- Independent sources include the Virginia Commonwealth University Medical Center and the American Association of Mechanical Engineers. Data of file at LifeNet Health.
- Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG.” 2007 Bio-Implants Brief
Clinical Application
- Joint Arthroplasty
- Tumor Resection and Reconstruction
- Fracture Management
- Deformity Correction
- Corpectomy
- Anterior Cervical Fusion
| Freeze-Dried | Description | Size |
|---|---|---|
| FEM 6.0 | Femoral Shaft | L = 60 mm |
| FEM | Femoral Shaft | L = 100 mm |
| Frozen | Description | Size |
|---|---|---|
| FFSS | Femoral Shaft | L = 100 mm |
| FFS | Femoral Shaft | L ≥ 200 mm |
| Preservon | Description | Size |
|---|---|---|
| PFEM 6.0 | Femoral Shaft | L = 60 mm |
| PFEM | Femoral Shaft | L = 100 mm |
Description
Cortical/cancellous shafts, designed to provide immediate structural support to restore segmental bone loss
- Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
- Structural: Cortical plate provides immediate structural support
- 100% Human Bone: Will remodel alongside patient’s own tissue during the healing process
- Pre-Hydrated: Allograft bio-implants featuring Preservon® are stored in a fully-hydrated state at ambient temperatures. Preservon eliminates thawing and re-hydration time and does not require freezer storage or compromise the graft’s inherent osteoconductive properties1
- Sterile: Sterilized using patented and proprietary Allowash XG® technology which provides a sterility assurance level (SAL) of 10-6, without compromising the graft’s inherent osteoconductive properties2
- Convenient: Implant is pre-sized to fit a variety of applications and minimize prep time in the operating room
- Independent sources include the Virginia Commonwealth University Medical Center and the American Association of Mechanical Engineers. Data of file at LifeNet Health.
- Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG.” 2007 Bio-Implants Brief
Clinical Application
- Joint Arthroplasty
- Tumor Resection and Reconstruction
- Fracture Management
- Deformity Correction
- Corpectomy
- Anterior Cervical Fusion
| Freeze-Dried | Description | Size |
|---|---|---|
| FIB 2.0 | Fibular Segment | L = 20 mm |
| FIB 4.0 | Fibular Segment | L = 40 mm |
| FIB 6.0 | Fibular Segment | L = 60 mm |
| FIB 8.0 | Fibular Segment | L = 80 mm |
| FIB | Fibular Segment | L = 100 mm |
| Frozen | Description | Size |
|---|---|---|
| FFIB 5.0 | Fibular Shaft | L = 50 mm |
| FFIB 10 | Fibular Shaft | L = 100 mm |
| FFIB | Fibular Shaft | L = 150 mm |
| FFIBS | Fibular Shaft | L ≥ 200 mm |
| Preservon | Description | Size |
|---|---|---|
| PFIB 2.0 | Fibular Shaft | L = 20 mm |
| PFIB 4.0 | Fibular Shaft | L = 40 mm |
| PFIB 6.0 | Fibular Shaft | L = 60 mm |
| PFIB 8.0 | Fibular Shaft | L = 80 mm |
| PFIB | Fibular Shaft | L = 100 mm |
Description
Cortical/cancellous shafts, designed to provide immediate structural support to restore segmental bone loss
- Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
- Structural: Cortical plate provides immediate structural support
- 100% Human Bone: Will remodel alongside patient’s own tissue during the healing process
- Pre-Hydrated: Allograft bio-implants featuring Preservon® are stored in a fully-hydrated state at ambient temperatures. Preservon eliminates thawing and re-hydration time and does not require freezer storage or compromise the graft’s inherent osteoconductive properties1
- Sterile: Sterilized using patented and proprietary Allowash XG® technology which provides a sterility assurance level (SAL) of 10-6, without compromising the graft’s inherent osteoconductive properties2
- Convenient: Implant is pre-sized to fit a variety of applications and minimize prep time in the operating room
- Independent sources include the Virginia Commonwealth University Medical Center and the American Association of Mechanical Engineers. Data of file at LifeNet Health.
- Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG.” 2007 Bio-Implants Brief
Clinical Application
- Joint Arthroplasty
- Tumor Resection and Reconstruction
- Fracture Management
- Deformity Correction
- Corpectomy
- Anterior Cervical Fusion
| Freeze-Dried | Description | Size |
|---|---|---|
| TIB 6.0 | Tibial Segment | L = 60 mm |
| TIB | Tibial Segment | L = 100 mm |
| Frozen | Description | Size |
|---|---|---|
| FTSS | Tibial Segment | L = 100 mm |
| FTS | Tibial Segment | L ≥ 200 mm |
Description
Cortical/cancellous shafts, designed to provide immediate structural support to restore segmental bone loss
- Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
- Structural: Cortical plate provides immediate structural support
- 100% Human Bone: Will remodel alongside patient’s own tissue during the healing process
- Pre-Hydrated: Allograft bio-implants featuring Preservon® are stored in a fully-hydrated state at ambient temperatures. Preservon eliminates thawing and re-hydration time and does not require freezer storage or compromise the graft’s inherent osteoconductive properties1
- Sterile: Sterilized using patented and proprietary Allowash XG® technology which provides a sterility assurance level (SAL) of 10-6, without compromising the graft’s inherent osteoconductive properties2
- Convenient: Implant is pre-sized to fit a variety of applications and minimize prep time in the operating room
- Independent sources include the Virginia Commonwealth University Medical Center and the American Association of Mechanical Engineers. Data of file at LifeNet Health.
- Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG.” 2007 Bio-Implants Brief
Clinical Application
- Joint Arthroplasty
- Tumor Resection and Reconstruction
- Fracture Management
- Deformity Correction
- Corpectomy
- Anterior Cervical Fusion
| Frozen | Description | Size |
|---|---|---|
| FHSS | Humeral Shaft | L ≥ 200 mm |
Description
Cortical struts, designed to reinforce cortical defects and provide immediate structural support
- Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
- Structural: Cortical graft provides immediate structural support
- 100% Human Bone: Can remodel with a patient’s own tissue during the healing process
- Pre-Hydrated: Allograft bio-implants featuring Preservon® are stored in a fully-hydrated state at ambient temperatures. Preservon eliminates thawing and re-hydration time and does not require freezer storage or compromise the graft’s inherent osteoconductive properties1
- Sterile: Sterilized using patented and proprietary Allowash XG technology which provides a sterility assurance level (SAL) of 10-6, without compromising the graft’s inherent osteoconductive properties2
- Convenient: Implant is pre-sized to fit a variety of applications and minimize prep time in the operating room
- Independent sources include the Virginia Commonwealth University Medical Center and the American Association of Mechanical Engineers. Data of file at LifeNet Health.
- Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG®.” 2007 Bio-Implants Brief.
Clinical Application
- Fracture Management
- Joint Arthroplasty
| Freeze-Dried | Description | Size |
|---|---|---|
| CMS | Cortical Matchsticks (6/pkg.) | 5 mm x 100 mm |
Description
Cortical struts, designed to reinforce cortical defects and provide immediate structural support
- Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
- Structural: Cortical graft provides immediate structural support
- 100% Human Bone: Can remodel with a patient’s own tissue during the healing process
- Pre-Hydrated: Allograft bio-implants featuring Preservon® are stored in a fully-hydrated state at ambient temperatures. Preservon eliminates thawing and re-hydration time and does not require freezer storage or compromise the graft’s inherent osteoconductive properties1
- Sterile: Sterilized using patented and proprietary Allowash XG technology which provides a sterility assurance level (SAL) of 10-6, without compromising the graft’s inherent osteoconductive properties2
- Convenient: Implant is pre-sized to fit a variety of applications and minimize prep time in the operating room
- Independent sources include the Virginia Commonwealth University Medical Center and the American Association of Mechanical Engineers. Data of file at LifeNet Health.
- Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG®.” 2007 Bio-Implants Brief.
Clinical Application
- Fracture Management
- Joint Arthroplasty
| Frozen | Description | Size |
|---|---|---|
| FTCS | Tibial Cortical Strut (1/pkg.) | L = 20 x 200 mm |
| Freeze-Dried | Description | Size |
|---|---|---|
| CST | Tibial Cortical Strut 2/pkg.) | L = 15 x 100 mm |
| CSTI | Tibial Cortical Strut (1/pkg.) | L = 15 x 100 mm |
Description
Cortical struts, designed to reinforce cortical defects and provide immediate structural support
- Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
- Structural: Cortical graft provides immediate structural support
- 100% Human Bone: Can remodel with a patient’s own tissue during the healing process
- Pre-Hydrated: Allograft bio-implants featuring Preservon® are stored in a fully-hydrated state at ambient temperatures. Preservon eliminates thawing and re-hydration time and does not require freezer storage or compromise the graft’s inherent osteoconductive properties1
- Sterile: Sterilized using patented and proprietary Allowash XG technology which provides a sterility assurance level (SAL) of 10-6, without compromising the graft’s inherent osteoconductive properties2
- Convenient: Implant is pre-sized to fit a variety of applications and minimize prep time in the operating room
- Independent sources include the Virginia Commonwealth University Medical Center and the American Association of Mechanical Engineers. Data of file at LifeNet Health.
- Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG®.” 2007 Bio-Implants Brief.
Clinical Application
- Fracture Management
- Joint Arthroplasty
| Frozen | Description | Size |
|---|---|---|
| FCS | Cortical Strut (1/pkg.) | L = 20 x 200 mm |
| FCS1.0 | Cortical Strut (1/pkg.) | L = 10 x 45 mm |
| FCS1.5 | Cortical Strut (1/pkg.) | L = 15 x 120 mm |
| FCSQ | Cortical Strut Quarter (1/pkg.) | L > 210 mm |
| FBFS | Femoral Bisected Shaft (1/pkg.) | L > 210 mm |
| Freeze-Dried | Description | Size |
|---|---|---|
| CS | Cortical Strut (2/pkg.) | 15 mm x 100 mm |
| CS1 | Cortical Strut (1/pkg.) | 15 mm x 100 mm |
Description
MatriGRAFT® Distal Femur portion of the femur inclusive of the femoral condyles, designed to provide immediate structural support to restore segmental bone loss
- Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
- Structural: Cortical plate provides immediate structural support
- 100% Human Bone: Can remodel with the patient’s own tissue during the healing process
- Sterile: Sterilized using patented and proprietary Allowash XG® technology which provides a sterility assurance level (SAL) of 10-6, without compromising the graft’s inherent osteoconductive properties1
- Convenient: Implant is pre-sized to fit a variety of applications and minimize prep time in the operating room
1 Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG.” 2007 Bio-Implants Brief.
Clinical Application
- Joint Arthroplasty
- Tumor Resection and Reconstruction
- Fracture Management
- Deformity Correction
Femoral Hemi-Condyle, Femoral Condyle
| Frozen | Description | Size |
|---|---|---|
| FDF | Distal Femur | Size Varies |
Description
MatriGRAFT® Proximal Femur end of the femur measured from the tip of the greater trochanter; includes femoral head
Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
Structural: Cortical plate provides immediate structural support
100% Human Bone: Can remodel with the patient’s own tissue during the healing process
Sterile: Sterilized using patented and proprietary Allowash XG® technology which provides a sterility assurance level (SAL) of 10-6, without compromising the graft’s inherent osteoconductive properties1
Convenient: Implant is pre-sized to fit a variety of applications and minimize prep time in the operating room
1 Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG.” 2007 Bio-Implants Brief.
Clinical Application
- Total Joint Arthroplasty
- Fracture Management
- Tumor Resection
Proximal Femur (without head), Femoral Shaft/Segment
| Frozen | Description | Size |
|---|---|---|
| FPFH | Proximal Femur w/ Head | Size Varies |
Description
MatriGRAFT® Proximal Femur end of the femur, including greater trochanter
- Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
- Structural: Cortical plate provides immediate structural support
- 100% Human Bone: Can remodel with the patient’s own tissue during the healing process
- Sterile: Sterilized using patented and proprietary Allowash XG® technology which provides a sterility assurance level (SAL) of 10-6, without compromising the graft’s inherent osteoconductive properties1
- Convenient: Implant is pre-sized to fit a variety of applications and minimize prep time in the operating room
1 Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG.” 2007 Bio-Implants Brief.
Clinical Application
- Tumor Resection
- Trauma Cases
- Total Joint Arthroplasty
Proximal Femur (with head), Femoral Shaft/Segment
| Frozen | Description | Size |
|---|---|---|
| FPF | Proximal Femur w/o head | Size Varies |
Description
Tricortical iliac crest wedge, designed to provide immediate structural support and restore segmental bone loss
Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
Structural: Tricortical plate provides immediate structural support
100% Human Bone: Can remodel with the patient’s own tissue during the healing process
Pre-Hydrated: Allograft bio-implants featuring Preservon® are stored in a fully-hydrated state at ambient temperatures. Preservon eliminates thawing and re-hydration time and does not require freezer storage or compromise the graft’s inherent osteoconductive properties1
Sterile: Sterilized using patented and proprietary Allowash XG® technology which provides a sterility assurance level (SAL) of 10-6, without compromising the graft’s inherent osteoconductive properties2
Convenient: Implant is pre-sized to fit a variety of applications and minimize prep time in the operating room
- Independent sources include the Virginia Commonwealth University Medical Center and the American Association of Mechanical Engineers. Data of file at LifeNet Health.
- Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG.” 2007 Bio-Implants Brief.
Clinical Application
- High Tibial Osteotomies
- Pelvic Osteotomies
- Foot & Ankle Osteotomies
- Fracture Management
- Glenoid Reconstruction
- Anterior Cervical Discectomy and Fusion
- Corpectomy
| Preservon | Description | Size |
|---|---|---|
| PICW0.6 | Iliac Crest Wedge | H = 6 mm |
| PICW0.7 | Iliac Crest Wedge | H = 7 mm |
| PICW0.8 | Iliac Crest Wedge | H = 8 mm |
| PICW0.9 | Iliac Crest Wedge | H = 9 mm |
| PICW1 | Iliac Crest Wedge | H = 10 mm |
| PICW2 | Iliac Crest Wedge | H = 12 mm |
| PICW5 | Iliac Crest Wedge | H = 15 mm |
| PICW8 | Iliac Crest Wedge | H = 18 mm |
| PICWS | Iliac Crest Wedge | H = 20 mm |
| PICW2.5 | Iliac Crest Wedge | H = 25 mm |
| Freeze-Dried | Description | Size |
|---|---|---|
| ICW0.6 | Iliac Crest Wedge | H = 6 mm |
| ICW0.7 | Iliac Crest Wedge | H = 7 mm |
| ICW0.8 | Iliac Crest Wedge | H = 8 mm |
| ICW0.9 | Iliac Crest Wedge | H = 9 mm |
| ICW1 | Iliac Crest Wedge | H = 10 mm |
| ICW2 | Iliac Crest Wedge | H = 12 mm |
| ICW5 | Iliac Crest Wedge | H = 15 mm |
| ICW8 | Iliac Crest Wedge | H = 18 mm |
| ICWS | Iliac Crest Wedge | H = 20 mm |
| ICW2.5 | Iliac Crest Wedge | H = 25 mm |
| ICW5 | Iliac Crest Wedge | H = 15 mm |
Description
Tricortical wedge, designed to provide immediate structural support and restore segmental bone loss
- Osteoconductive: Natural osteoconductive scaffold allows for cellular attachment and vascular in-growth
- Structural: Tricortical plate provides immediate structural support
- 100% Human Bone: Will remodel alongside patient’s own tissue during healing process
- Sterile: Sterilized using proprietary and patented Allowash XG® technology. This technology provides a sterility assurance level of 10-6, without compromising the implant’s inherent osteoconductive properties1
- Convenient: Implant is pre-sized to fit a variety of applications and minimize prep time in the operating room
- Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG.” 2007 Bio-Implants Brief.
Clinical Application
- Tibial Wedge Osteotomies
- Pelvic Osteotomies
- Foot & Ankle Arthrodesis
| Freeze-Dried | Description | Size |
|---|---|---|
| PAT.WEDGE | Tricortical Patellar Wedge | H = 12 mm |
| PAT.WEDGE5 | Tricortical Patellar Wedge | H = 15 mm |
| PAT.WEDGE8 | Tricortical Patellar Wedge | H = 18 mm |
Description
Dense cancellous bio-implants with intact cortical plate, designed to provide immediate structural support and restore segmental bone loss
- Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
- Structural: Cortical plate provides immediate structural support
- 100% Human Bone: Will remodel alongside patient’s own tissue during the healing process
- Pre-Hydrated: Allograft bio-implants featuring Preservon are stored in a fully-hydrated state at ambient temperatures. Preservon eliminates thawing and re-hydration time and does not require freezer storage or compromise the graft’s inherent osteoconductive properties1
- Sterile: Sterilized using patented and proprietary Allowash XG technology which provides a sterility assurance level (SAL) of 10-6, without compromising the graft’s inherent osteoconductive properties2
- Convenient: Implant is pre-sized to fit a variety of applications and minimize prep time in the operating room
- Independent sources include the Virginia Commonwealth University Medical Center and the American Association of Mechanical Engineers. Data of file at LifeNet Health.
- Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG®.” 2007 Bio-Implants Brief.
Clinical Application
- Calcaneal Osteotomies
- Fracture Management
- Foot & Ankle Fusion
- Subtalar Joint Fusion
| Freeze-Dried | Description | Size |
|---|---|---|
| POD.WEDGE | Calcaneus Wedge | H = 15 mm |
| POD.WEDGE8 | Calcaneus Wedge | H = 18 mm |
Description
Femoral and humeral heads, designed to provide immediate structural support to restore segmental bone loss or to be ground into cortical/cancellous chips
- Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
- Structural: Cortical wall provides immediate structural support
- 100% Human Bone: Can remodel with a patient’s own tissue during the healing process
- Sterile: Sterilized using patented and proprietary Allowash XG® technology which provides a sterility assurance level (SAL) of 10-6, without compromising the graft’s inherent osteoconductive properties1
- Convenient: Implant is pre-sized to fit a variety of applications and minimize prep time in the operating room
- Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG.” 2007 Bio-Implants Brief.
Clinical Application
- Joint Arthroplasty
- Fracture Management
- Creating Custom Wedges or Segments
- Filling Osseous Defects
| Frozen | Description | Size |
|---|---|---|
| FHH | Humeral Head | D ≥ 43 mm |
Description
Femoral and humeral heads, designed to provide immediate structural support to restore segmental bone loss or to be ground into cortical/cancellous chips
- Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
- Structural: Cortical wall provides immediate structural support
- 100% Human Bone: Can remodel with a patient’s own tissue during the healing process
- Sterile: Sterilized using patented and proprietary Allowash XG® technology which provides a sterility assurance level (SAL) of 10-6, without compromising the graft’s inherent osteoconductive properties1
- Convenient: Implant is pre-sized to fit a variety of applications and minimize prep time in the operating room
- Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG.” 2007 Bio-Implants Brief.
Clinical Application
- Joint Arthroplasty
- Fracture Management
- Creating Custom Wedges or Segments
- Filling Osseous Defects
| Frozen | Description | Size |
|---|---|---|
| FFH | Femoral Head | D ≥ 43 mm |
| FFHG | Femoral Head (Grinder) | D Varies |
| FFHN | Femoral Head w/ Neck | L ≥ 43 mm (Neck L = 10 - 12 mm) |
Description
MatriGRAFT® Structural Repair Rib segment with varying shape due to donor anatomy
- Processed using LifeNet's patented Allowash® technology for disinfection and cleaning to enhance the safety of allograft tissue
Clinical Application
- Correction of Ridge defects
- Facial reconstruction
Illium Strip
| Freeze-Dried | Description | Size |
|---|---|---|
| RIB | Rib | L = 60 - 115 mm |
Description
Intercalary femur segments and condyles, designed to provide immediate structural support to restore segmental bone loss
- Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
- Structural: Cortical plate provides immediate structural support
- 100% Human Bone: Can remodel with the patient’s own tissue during the healing process
- Sterile: Sterilized using patented and proprietary Allowash XG® technology which provides a sterility assurance level (SAL) of 10-6, without compromising the graft’s inherent osteoconductive properties1
- Convenient: Implant is pre-sized to fit a variety of applications and minimize prep time in the operating room
- Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG.” 2007 Bio-Implants Brief.
Clinical Application
- Joint Arthroplasty
- Tumor Resection and Reconstruction
- Fracture Management
- Deformity Correction
| Frozen | Description | Size |
|---|---|---|
| FHC | Femoral Hemi-Condyle | Lateral or Medial L = 50 - 70 mm |
Description
Intercalary femur segments and condyles, designed to provide immediate structural support to restore segmental bone loss
- Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
- Structural: Cortical plate provides immediate structural support
- 100% Human Bone: Can remodel with the patient’s own tissue during the healing process
- Sterile: Sterilized using patented and proprietary Allowash XG® technology which provides a sterility assurance level (SAL) of 10-6, without compromising the graft’s inherent osteoconductive properties1
- Convenient: Implant is pre-sized to fit a variety of applications and minimize prep time in the operating room
- Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG.” 2007 Bio-Implants Brief.
Clinical Application
- Joint Arthroplasty
- Tumor Resection and Reconstruction
- Fracture Management
- Deformity Correction
| Frozen | Description | Size |
|---|---|---|
| FWC | Femoral Whole-Condyle | Lateral or Medial L = 50 - 70 mm |
Description
Sterile cancellous cubes and blocks designed for use in well-defined bone voids
- Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
- Pre-hydrated: Allograft bio-implants featuring Preservon® are stored in a fully-hydrated state at ambient temperatures. Preservon eliminates thawing and re-hydration time, does not require freezer storage, and does not compromise the graft’s inherent osteoconductive properties1
- Sterile: Sterilized using proprietary and patented Allowash XG® technology which provides a sterility assurance level of 10-6, without compromising the graft’s inherent osteoconductive properties2
- Versatile: Available in multiple sizes and volumes to meet surgical needs
- Absorbent: Absorbs and retains bioactive fluids like blood, platelet rich plasma (PRP), and bone marrow aspirate (BMA)
- Independent sources include the Virginia Commonwealth University Medical Center and the American Association of Mechanical Engineers. Data of file at LifeNet Health.
- Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG®.” 2007 Bio-Implants Brief
Clinical Application
- Any surgical application that requires bone void filler
- ReadiGraft Cancellous Chips
- ReadiGraft Cortical/Cancellous Chips
- MatriGraft Femoral Head (Grinder)
| Freeze-Dried | Description | Size |
|---|---|---|
| CANBLOCK | Cancellous Block | 20 x 20 x 30 mm |
| CANCUBE05 S | Cancellous Cubes | 0.5 x 0.5 x 0.5 cm (5 cc) |
| CANCUBE15 S | Cancellous Cubes | 0.5 x 0.5 x 0.5 cm (15 cc) |
| CANCUBE1/4 | Cancellous Cubes | 1.0 x 1.0 x 1.0 cm (20 cc) |
| CANCUBE30 | Cancellous Cubes | 1.0 x 1.0 x 1.0 cm (30 cc) |
| CANCUBE1/2 | Cancellous Cubes | 1.0 x 1.0 x 1.0 cm (40 cc) |
| Preservon | Description | Size |
|---|---|---|
| PCANBLOCK | Cancellous Block | 20 x 20 x 30 mm |
| CANCUBE05 SP | Cancellous Cubes | 0.5 x 0.5 x 0.5 cm (5 cc) |
| CANCUBE15 SP | Cancellous Cubes | 0.5 x 0.5 x 0.5 cm 15 cc |
| PCANCUBE1/4 | Cancellous Cubes | 1.0 x 1.0 x 1.0 cm (20 cc) |
| PCANCUBE30 | Cancellous Cubes | 1.0 x 1.0 x 1.0 cm (30 cc) |
| PCANCUBE1/2 | Cancellous Cubes | 1.0 x 1.0 x 1.0 cm (40 cc) |
Description
Demineralized bone chips and particulates designed to promote bone healing in patients with a high risk of non-union
- Osteoinductive Potential: Demineralized using proprietary PAD® technology that targets optimal residual calcium levels of 1-4% without compromising the grafts inherent osteoconductive properties or osteoinductive potential1-4
- Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
- Sterile: Sterilized using proprietary and patented Allowash XG® technology which provides a sterility assurance level of 10-6, without compromising the graft’s inherent osteoconductive properties5
- Versatile: Available in multiple sizes and volumes to meet surgical needs
- Absorbent: Absorbs and retains bioactive fluids like blood, platelet rich plasma (PRP), and bone marrow aspirate (BMA)
- Zhang M, Powers R, Wolfinbarger L. (1997). Effect(s) of demineralization process on the osteoinductivity of demineralized bone matrix. J Periodontol, 68:1085-1092.
- Turonis JW, McPherson JC 3rd, Cuening MF. (2006). The affects of residual calcium in decalcified freeze-dried bone allograft in a critical-sized defect in the Rattus norvegicus calvarium. J Oral Implantol. 32(2), 55-62.
- Herold RW, Pashley DH, Cuening MF. (2002). Effects of varying degrees of allograft decalcification on the cultured porcine osteoclast cells. J Periodontol, 72(2), 213-219.
- Mott DA, Mailhot J, Cuenin MF, Sharawy M, Borke J. (2002). Enhancement of osteoblast proliferation in vitro by selective enrichment of demineralized freeze-dried bone allograft with specific growth factors. J Oral Implantiol, 28(2), 57-66.
- Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG®.” 2007 Bio-Implants Brief.
Clinical Application
- Any surgical application that requires bone void filler
| Freeze-Dried | Description | Size |
|---|---|---|
| DCAN40 | Demineralized Cancellous, 1 - 4 mm | 40 cc |
Description
Demineralized bone chips and particulates designed to promote bone healing in patients with a high risk of non-union
- Osteoinductive Potential: Demineralized using proprietary PAD® technology that targets optimal residual calcium levels of 1-4% without compromising the grafts inherent osteoconductive properties or osteoinductive potential1-4
- Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
- Sterile: Sterilized using proprietary and patented Allowash XG® technology which provides a sterility assurance level of 10-6, without compromising the graft’s inherent osteoconductive properties5
- Versatile: Available in multiple sizes and volumes to meet surgical needs
- Absorbent: Absorbs and retains bioactive fluids like blood, platelet rich plasma (PRP), and bone marrow aspirate (BMA)
- Zhang M, Powers R, Wolfinbarger L. (1997). Effect(s) of demineralization process on the osteoinductivity of demineralized bone matrix. J Periodontol, 68:1085-1092.
- Turonis JW, McPherson JC 3rd, Cuening MF. (2006). The affects of residual calcium in decalcified freeze-dried bone allograft in a critical-sized defect in the Rattus norvegicus calvarium. J Oral Implantol. 32(2), 55-62.
- Herold RW, Pashley DH, Cuening MF. (2002). Effects of varying degrees of allograft decalcification on the cultured porcine osteoclast cells. J Periodontol, 72(2), 213-219.
- Mott DA, Mailhot J, Cuenin MF, Sharawy M, Borke J. (2002). Enhancement of osteoblast proliferation in vitro by selective enrichment of demineralized freeze-dried bone allograft with specific growth factors. J Oral Implantiol, 28(2), 57-66.
- Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG®.” 2007 Bio-Implants Brief.
Clinical Application
- Any surgical application that requires bone void filler
| Freeze-Dried | Description | Size |
|---|---|---|
| DGC20 | Demineralized Cortical Chips 125 - 1000 microns | 20 cc |
| DGC40 | Demineralized Cortical Chips 125 - 1000 microns | 40 cc |
Description
ReadiGRAFT® Fascia Lata is a fibrous covering of muscle recovered from the lateral aspect of the thigh
- Allows physician to use for various clinical applications
Clinical Application
- Dural replacement
- Blepharoplasty (Drooped Eyelid Repair)
- Reconstruction of rotator cuff, ACL, and PCL
For Duraplasty: Pericardium
Achilles Tendon, Patellar Ligament, Tibial Tendons, Semitendinosus, Gracilis
| Freeze-Dried | Description | Size |
|---|---|---|
| FL STRIP | Fascia Lata - Strip | 3 mm x 150 mm |
| FL S | Fascia Lata - Small | 30 mm x 60 mm |
| FL M | Fascia Lata - Medium | 30 mm x 150 mm |
| FL L | Fascia Lata - Large | 80 mm x 200 mm |
Description
ReadiGRAFT® Pericardium is a sac-like membrane surrounding the heart
- Allows physician to use for various clinical applications
Clinical Application
- Dural replacement/repair
- Sceral substitute
Fascia Lata
| Freeze-Dried | Description | Size |
|---|---|---|
| PERI 1.5 | Pericardium | 15 mm X 15 mm |
| PERI S | Pericardium Small | 20 mm x 40 mm |
| PERI M | Pericardium Medium | 40 mm x 40 mm |
| PERI L | Pericardium Large | 60 mm x 60 mm |
Description
Optium® DBM Putty is designed to set the standard for safety, quality and performance in DBM technology
- Demineralized using LifeNet Health's patented and proprietary PAD® process which exposes natural growth factors trapped within cortical bone
- Every lot of final product is tested for osteoinductive potential
- Fibers provide a natural architecture with increased surface area to encourage cellular attachment
- LifeNet Health's patented Allowash XG® technology provides a sterility assurance level of 10-6
- Optium's carrier, glycerol, gives it an extensive, published clinical history and proven safe and effective in bone void filling applications
- Ready to use
- Available in different volumes
Clinical Application
- Joint Reconstruction and Revision
- Trauma
- Spine
I/C Graft Chamber®and Optium® DBM Gel
| Freeze-Dried | Description | Size |
|---|---|---|
| TPUT01 | Putty (DBM Fibers & Glycerol) | 1 cc |
| TPUT02 | Putty (DBM Fibers & Glycerol) | 2.5 cc |
| TPUT05 | Putty (DBM Fibers & Glycerol) | 5 cc |
| TPUT10 | Putty (DBM Fibers & Glycerol) | 10 cc |
Description
Optium® DBM Gel is designed to set the standard for safety, quality and performance in DBM technology
- Demineralized using LifeNet Health's patented and proprietary PAD® process which exposes natural growth factors trapped within cortical bone
- Every lot of final product is tested for osteoinductive potential
- Fibers provide a natural architecture with increased surface area to encourage cellular attachment
- LifeNet Health's patented Allowash XG® technology provides a sterility assurance level of 10-6
- Optium's carrier, glycerol, gives it an extensive, published clinical history and proven safe and effective in bone void filling applications
- Ready to use
- Available in different volumes
Clinical Application
- Joint Reconstruction and Revision
- Trauma
- Spine
| Freeze-Dried | Description | Size |
|---|---|---|
| TGEL01 | Gel (Particulate DBM & Glycerol) | 1 cc |
| TGEL05 | Gel (Particulate DBM & Glycerol) | 5 cc |
| TGEL10 | Gel (Particulate DBM & Glycerol) | 10 cc |
Description
Demineralized bone chips and particulates designed to promote bone healing in patients with a high risk of non-union
- Osteoinductive Potential: Demineralized using proprietary PAD® technology that targets optimal residual calcium levels of 1-4% without compromising the grafts inherent osteoconductive properties or osteoinductive potential1-4
- Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
- Sterile: Sterilized using proprietary and patented Allowash XG® technology which provides a sterility assurance level of 10-6, without compromising the graft’s inherent osteoconductive properties5
- Versatile: Available in multiple sizes and volumes to meet surgical needs
- Absorbent: Absorbs and retains bioactive fluids like blood, platelet rich plasma (PRP), and bone marrow aspirate (BMA)
- Zhang M, Powers R, Wolfinbarger L. (1997). Effect(s) of demineralization process on the osteoinductivity of demineralized bone matrix. J Periodontol, 68:1085-1092.
- Turonis JW, McPherson JC 3rd, Cuening MF. (2006). The affects of residual calcium in decalcified freeze-dried bone allograft in a critical-sized defect in the Rattus norvegicus calvarium. J Oral Implantol. 32(2), 55-62.
- Herold RW, Pashley DH, Cuening MF. (2002). Effects of varying degrees of allograft decalcification on the cultured porcine osteoclast cells. J Periodontol, 72(2), 213-219.
- Mott DA, Mailhot J, Cuenin MF, Sharawy M, Borke J. (2002). Enhancement of osteoblast proliferation in vitro by selective enrichment of demineralized freeze-dried bone allograft with specific growth factors. J Oral Implantiol, 28(2), 57-66.
- Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG®.” 2007 Bio-Implants Brief.
Clinical Application
- Any surgical application that requires bone void filler
| Freeze-Dried | Description | Size |
|---|---|---|
| DCC1/4 | Demineralized Cortical/Cancellous | 20 cc |
Description
Demineralized bone chips and particulates designed to promote bone healing in patients with a high risk of non-union
- Osteoinductive Potential: Demineralized using proprietary PAD® technology that targets optimal residual calcium levels of 1-4% without compromising the grafts inherent osteoconductive properties or osteoinductive potential1-4
- Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
- Sterile: Sterilized using proprietary and patented Allowash XG® technology which provides a sterility assurance level of 10-6, without compromising the graft’s inherent osteoconductive properties5
- Versatile: Available in multiple sizes and volumes to meet surgical needs
- Absorbent: Absorbs and retains bioactive fluids like blood, platelet rich plasma (PRP), and bone marrow aspirate (BMA)
- Zhang M, Powers R, Wolfinbarger L. (1997). Effect(s) of demineralization process on the osteoinductivity of demineralized bone matrix. J Periodontol, 68:1085-1092.
- Turonis JW, McPherson JC 3rd, Cuening MF. (2006). The affects of residual calcium in decalcified freeze-dried bone allograft in a critical-sized defect in the Rattus norvegicus calvarium. J Oral Implantol. 32(2), 55-62.
- Herold RW, Pashley DH, Cuening MF. (2002). Effects of varying degrees of allograft decalcification on the cultured porcine osteoclast cells. J Periodontol, 72(2), 213-219.
- Mott DA, Mailhot J, Cuenin MF, Sharawy M, Borke J. (2002). Enhancement of osteoblast proliferation in vitro by selective enrichment of demineralized freeze-dried bone allograft with specific growth factors. J Oral Implantiol, 28(2), 57-66.
- Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG®.” 2007 Bio-Implants Brief.
Clinical Application
- Any surgical application that requires bone void filler
| Freeze-Dried | Description | Size |
|---|---|---|
| DGC20 | Demineralized Cortical Chips 125 - 1000 microns | 20 cc |
| DGC40 | Demineralized Cortical Chips 125 - 1000 microns | 40 cc |
Description
ReadiGRAFT® BLX Fibers are a proprietary mix of demineralized cortical fibers and mineralized cancellous chips
*For international markets only
- Cortical fibers are demineralized using LifeNet Health's patented and proprietary PAD® technology
- Contains no carriers commonly used in putties and gels
- Allows surgeons to customize hydration options
- Comprised of 100% natural bone which is remodeled naturally during the bone healing process
- LifeNet Health's patented Allowash XG® technology provides a sterility assurance level of 10-6
Clinical Application
- Any surgical application that requires bone void filler
| Freeze-Dried | Description | Size |
|---|---|---|
| DF-1002 | BLX DBM Fibers | 2 cc |
| DF-1003 | BLX DBM Fibers | 5 cc |
| DF-1004 | BLX DBM Fibers | 15 cc |
| DF-1005 | BLX DBM Fibers | 30 cc |
Description
A natural mix of cortical and cancellous bone chips designed to encourage bi-phasic remodeling
- Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
- Bi-Phasic: Natural mix of cortical and cancellous bone facilitates bi-phasic remodeling
- Pre-hydrated: Allograft bio-implants featuring Preservon® are stored in a fully-hydrated state at ambient temperatures. Preservon eliminates thawing and re-hydration time, does not require freezer storage, and does not compromise the graft’s inherent osteoconductive properties1
- Sterile: Sterilized using proprietary and patented Allowash XG® technology which provides a sterility assurance level of 10-6, without compromising the graft’s inherent osteoconductive properties2
- Versatile: Available in grind sizes of 1-4 mm or 1-8 mm in multiple volumes to meet surgical needs
- Absorbent: Absorbs and retains bioactive fluids like blood, platelet rich plasma (PRP), and bone marrow aspirate (BMA)
- Independent sources include the Virginia Commonwealth University Medical Center and the American Association of Mechanical Engineers. Data of file at LifeNet Health.
- Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG®.” 2007 Bio-Implants Brief.
Clinical Application
- Any surgical application that requires bone void filler
- ReadiGraft Cancellous Chips
- MatriGraft Femoral Head (Grinder)
| Preservon | Description | Size |
|---|---|---|
| PCC15 14 | Cortical/Cancellous 1 -4 mm | 15 cc |
| PCC30 14 | Cortical/Cancellous 1 - 4 mm | 30 cc |
| PCC60 14 | Cortical/Cancellous 1 - 4 mm | 60 cc |
| PCC90 14 | Cortical/Cancellous 1 - 4 mm | 90 cc |
| PCC10 | Cortical/Cancellous 1 - 8 mm | 10 cc |
| PCC15 | Cortical/Cancellous 1 - 8 mm | 15 cc |
| PCC1/4 | Cortical/Cancellous 1 -8 mm | 20 cc |
| PCC30 | Cortical/Cancellous 1- 8 mm | 30 cc |
| PCC1/2 | Cortical/Cancellous 1 - 8 mm | 40cc |
| PCC60 | Cortical/Cancellous 1 - 8 mm | 60 cc |
| PCC90 | Cortical/Cancellous 1- 8 mm | 90 cc |
| Freeze-Dried | Description | Size |
|---|---|---|
| CC10 | Cortical/Cancellous 1 - 8 mm | 10 cc |
| CC1/4 | Cortical/Cancellous 1 - 8 mm | 20 cc |
| CC30 | Cortical/Cancellous 1 - 8 mm | 30 cc |
| CC1/2 | Cortical/Cancellous 1 - 8 mm | 40 cc |
| CC60 | Cortical/Cancellous 1 - 8 mm | 60 cc |
| CC90 | Cortical/Cancellous 1 - 8 mm | 90 cc |
Description
Optimally demineralized1-5 putty that provides a natural osteoconductive scaffold and osteoinductive potential to encourage bone healing and fusion
*For International Markets Only
- Osteoinductive Potential: Demineralized using proprietary PAD® technology that targets optimal residual calcium levels of 1-4% without compromising the grafts inherent osteoconductive properties or osteoinductive potential1-4
- Excellent Handling Properties: Designed to be molded into any shape, conform to the defect site, and resist migration under irrigation
- Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
- Sterile: Sterilized using proprietary and patented Allowash XG technology which provides a sterility assurance level of 10-6, without compromising the graft’s inherent osteoconductive properties or osteoinductive potential5
- Ready-to-Use: No rehydration or thawing required, saving valuable operating room time
- Convenient Syringe: Syringe design allows for controlled extrusion of the graft
- Versatile: Available with or without cortical/cancellous chips in multiple volumes to meet surgical needs
- Zhang M, Powers R, Wolfinbarger L. (1997). Effect(s) of demineralization process on the osteoinductivity of demineralized bone matrix. J Periodontol, 68:1085-1092.
- Turonis JW, McPherson JC 3rd, Cuening MF. (2006). The affects of residual calcium in decalcified freeze-dried bone allograft in a critical-sized defect in the Rattus norvegicus calvarium. J Oral Implantol. 32(2), 55-62.
- Herold RW, Pashley DH, Cuening MF. (2002). Effects of varying degrees of allograft decalcification on the cultured porcine osteoclast cells. J Periodontol, 72(2), 213-219.
- Mott DA, Mailhot J, Cuenin MF, Sharawy M, Borke J. (2002). Enhancement of osteoblast proliferation in vitro by selective enrichment of demineralized freeze-dried bone allograft with specific growth factors. J Oral Implantiol, 28(2), 57-66.
- Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG®.” 2007 Bio-Implants Brief.
Clinical Application
- Any surgical application that requires bone void filler
| Freeze-Dried | Description | Size |
|---|---|---|
| BF-1000-001 | DBM Putty | 0.5 cc |
| BF-1000-002 | DBM Putty | 1.0 cc |
| BF-1000-003 | DBM Putty | 2.5 cc |
| BF-1000-004 | DBM Putty | 5.0 cc |
| BF-1000-005 | DBM Putty | 10.0 cc |
| BL-1400-001 | DBM Putty w/ CC | 0.5 cc |
| BL-1400-002 | DBM Putty w/ CC | 1.0 cc |
| BL-1400-003 | DBM Putty w/ CC | 2.5 cc |
| BL-1400-004 | DBM Putty w/ CC | 5.0 cc |
| BL-1400-005 | DBM Putty w/ CC | 10.0 cc |
Description
Sterile cancellous chips that provide a natural osteoconductive matrix to encourage bone healing
- Osteoconductive: Natural bone matrix facilitates cell attachment and proliferation, and vascular in-growth
- Pre-hydrated: Allograft bio-implants featuring Preservon® are stored in a fully-hydrated state at ambient temperatures. Preservon eliminates thawing and re-hydration time, does not require freezer storage, and does not compromise the graft’s inherent osteoconductive properties1
- Sterile: Sterilized using proprietary and patented Allowash XG® technology which provides a sterility assurance level of 10-6, without compromising the graft’s inherent osteoconductive properties2
- Versatile: Available in multiple grind sizes and volumes to meet surgical needs
- Absorbent: Absorbs and retains bioactive fluids like blood, platelet rich plasma (PRP), and bone marrow aspirate (BMA)
- Independent sources include the Virginia Commonwealth University Medical Center and the American Association of Mechanical Engineers. Data of file at LifeNet Health.
- Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG®.” 2007 Bio-Implants Brief
Clinical Application
- Any surgical application that requires bone void filler
- ReadiGraft Cancellous Cubes
- ReadiGraft Cortical/Cancellous Chips
- MatriGraft Femoral Head (Grinder)
| Freeze-Dried | Description | Size |
|---|---|---|
| CAN15 14BP | Crushed Cancellous Chips, 1 - 4 mm | 15 cc |
| CAN20 14BP | Crushed Cancellous Chips, 1 - 4 mm | 20 cc |
| CAN30 14BP | Crushed Cancellous Chips, 1 - 4 mm | 30cc |
| CAN40 14BP | Crushed Cancellous Chips, 1 - 4 mm | 40 cc |
| CAN60 14BP | Crushed Cancellous Chips, 1 - 4 mm | 60 cc |
| CAN80 14BP | Crushed Cancellous Chips, 1 - 4 mm | 80 cc |
| CAN90 14BP | Crushed Cancellous Chips, 1 - 4 mm | 90 cc |
| CAN5 | Crushed Cancellous Chips, 1 - 8 mm | 5 cc |
| CAN10 | Crushed Cancellous Chips, 1 - 8 mm | 10 cc |
| CAN15 | Crushed Cancellous Chips, 1 - 8 mm | 15 cc |
| CAN1/4 | Crushed Cancellous Chips, 1 - 8 mm | 20 cc |
| CAN30 | Crushed Cancellous Chips, 1 - 8 mm | 30 cc |
| CAN1/2 | Crushed Cancellous Chips, 1 - 8 mm | 40 cc |
| CAN60 | Crushed Cancellous Chips, 1 - 8 mm | 60 cc |
| CAN1 | Crushed Cancellous Chips, 1 - 8 mm | 80 cc |
| CAN90 | Crushed Cancellous Chips, 1 - 8 mm | 90 cc |
| CAN1 | Crushed Cancellous Chips, 1 - 8 mm | 80 cc |
| CAN15 410BP | Crushed Cancellous Chips, 4 - 10 mm | 15 cc |
| CAN30 410BP | Crushed Cancellous Chips, 4 - 10 mm | 30 cc |
| CAN60 410BP | Crushed Cancellous Chips, 4 - 10 mm | 60 cc |
| CAN90 410BP | Crushed Cancellous Chips, 4 - 10 mm | 90 cc |
| Frozen | Description | Size |
|---|---|---|
| FCAN1/4 | Crushed Cancellous Chips, 1 - 8 mm | 20 cc |
| FCAN30 | Crushed Cancellous Chips, 1 - 8 mm | 30 cc |
| FCAN1/2 | Crushed Cancellous Chips, 1 - 8 mm | 40 cc |
| FCAN1 | Crushed Cancellous Chips, 1 - 8 mm | 80 cc |
| FCAN90 | Crushed Cancellous Chips, 1 - 8 mm | 90 cc |
| FCAN2 | Crushed Cancellous Chips, 1 - 8 mm | 160 cc |
| FCAN15 14 | Crushed Cancellous Chips, 1 - 4 mm | 15 cc |
| FCAN30 14 | Crushed Cancellous Chips, 1 - 4 mm | 30 cc |
| FCAN60 14 | Crushed Cancellous Chips, 1 - 4 mm | 60 cc |
| FCAN90 14 | Crushed Cancellous Chips, 1 - 4 mm | 90 cc |
| FCAN15 410 | Crushed Cancellous Chips, 4 - 10 mm | 15 cc |
| FCAN30 410 | Crushed Cancellous Chips, 4 - 10 mm | 30 cc |
| FCAN60 410 | Crushed Cancellous Chips, 4 - 10 mm | 60 cc |
| FCAN90 410 | Crushed Cancellous Chips, 4 - 10 mm | 90 cc |
| Preservon | Description | Size |
|---|---|---|
| PCAN15 | Crushed Cancelleous Chips, 1 - 8 mm | 15 cc |
| PCAN90 14 | Crushed Cancellous Chips, 1 - 4 mm | 90 cc |
| PCAN60 410 | Crushed Cancellous Chips, 4 - 10 mm | 60 cc |
| PCAN30 410 | Crushed Cancellous Chips, 4 - 10 mm | 30 cc |
| PCAN15 410 | Crushed Cancellous Chips, 4 - 10 mm | 15 cc |
| PCAN1 | Crushed Cancellous Chips, 1- 8 mm | 80 cc |
| PCAN60 | Crushed Cancellous Chips, 1 - 8 mm | 60 cc |
| PCAN10 | Crushed Cancellous Chips, 1 - 8 mm | 10 cc |
| PCAN5 | Crushed Cancellous Chips, 1 - 8 mm | 5 cc |
| PCAN80 14 | Crushed Cancellous Chips, 1 - 4 mm | 80 cc |
| PCAN1/4 | Crushed Cancelleous Chips, 1 - 8 mm | 20 cc |
| PCAN60 14 | Crushed Cancellous Chips, 1 - 4 mm | 60 cc |
| PCAN40 14 | Crushed Cancellous Chips, 1 - 4 mm | 40 cc |
| PCAN30 14 | Crushed Cancellous Chips, 1 - 4 mm | 30 cc |
| PCAN20 14 | Crushed Cancellous Chips, 1 - 4 mm | 20 cc |
| PCAN15 14 | Crushed Cancellous Chips, 1 - 4 mm | 15 cc |
| PCAN90 | Crushed Cancelleous Chips, 1 - 8 mm | 90 cc |
| PCAN1/2 | Crushed Cancelleous Chips, 1 - 8 mm | 40 cc |
| PCAN30 | Crushed Cancelleous Chips, 1 - 8 mm | 30 cc |
| PCAN90 410 | Crushed Cancellous Chips, 4 - 10 mm | 90 cc |
Description
LifeNet Health has a complete portfolio of large segmental and reconstructive allograft bio-implants to meet the challenging demands of reconstructive procedures. We work in close collaboration with you and your staff to ensure the proper match for your patient. For a full listing of Osteoarticular allografts, click here.
Description
PliaFX Prime is 100% bone fibers, demineralized to encourage bone formation and healing. The fibers interlock, allowing the graft to become moldable upon rehydration without the use of a carrier.
- 100% Bone: Facilitates natural remodeling during the bone healing process (no human, xenograft or synthetic carriers)
- Osteoconductive: The large surface area and interconnected network of demineralized cortical fibers provides a scaffold that promotes cellular attachment and cell spreading1,2
- Osteoinductive Potential: Optimally demineralized by LifeNet Health’s proprietary PAD® technology to expose natural growth factors2-7
- Versatile: Moldable upon rehydration to conform to the surgical site
- Resists Migration: Interlocking fibers allow graft to remain intact and in place
- Safety: Sterilized using proprietary Allowash XG® technology, providing a sterility assurance level of 10-6 to reduce the risk of disease transmission without compromising the graft’s osteoconductive properties or osteoinductive potential2,8
- Convenience: Ambient storage and rapid rehydration
Clinical Application
Surgical procedures that require bone void filler
| Freeze-Dried | Description | Size |
|---|---|---|
| BL-1800-00 | Prime 100% bone fibers | 0.5 cc |
| BL-1800-01 | Prime 100% bone fibers | 1.0 cc |
| BL-1800-02 | Prime 100% bone fibers | 2.5 cc |
| BL-1800-05 | Prime 100% bone fibers | 5.0 cc |
| BL-1800-10 | Prime 100% bone fibers | 10.0 cc |